Vault-13

Omega Fund Management, LLC

Boston, MA · CIK 1637359 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2012 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Boston, MA (main office)United States United Statesabout 5
GenevaSwitzerland Switzerland3

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$185.7m reported value +13.8% vs Q1 2026
10positions
100.0%in top 10
1 new 0 added 1 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BICARA THERAPEUTICS INC COM BCAX BCAX 1,822,150 $54.1m29.14% 29.14% ReducedShares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 2.4m, Q2 2026 1.8m -570.0k -570,000 -23.8%
2 NUVATION BIO INC COM CL A NUVB NUVB 8,081,089 $45.9m24.72% 24.72% UnchangedShares held: Q3 2025 8.8m, Q4 2025 8.1m, Q1 2026 8.1m, Q2 2026 8.1m
3 KESTRA MED TECHNOLOGIES LTD SHS KMTS KMTS 1,022,149 $26.0m14.00% 14.00% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.4m, Q1 2026 1.0m, Q2 2026 1.0m
4 BRIDGEBIO ONCOLOGY THERAPEUT COM NEW BBOT BBOT 3,289,661 $25.1m13.50% 13.50% UnchangedShares held: Q3 2025 3.3m, Q4 2025 3.3m, Q1 2026 3.3m, Q2 2026 3.3m
5 BETA BIONICS INC COM BBNX BBNX 1,316,183 $20.6m11.11% 11.11% UnchangedShares held: Q3 2025 1.9m, Q4 2025 1.3m, Q1 2026 1.3m, Q2 2026 1.3m
6 ALUMIS INC COM ALMS ALMS 241,255 $6.8m3.66% 3.66% UnchangedShares held: Q3 2025 653.2k, Q4 2025 653.2k, Q1 2026 241.3k, Q2 2026 241.3k
7 SANA BIOTECHNOLOGY INC COM SANA SANA 843,750 $2.9m1.59% 1.59% UnchangedShares held: Q3 2025 843.8k, Q4 2025 843.8k, Q1 2026 843.8k, Q2 2026 843.8k
8 IMAGENEBIO INC COM IMA IMA 455,361 $2.7m1.45% 1.45% UnchangedShares held: Q3 2025 455.4k, Q4 2025 455.4k, Q1 2026 455.4k, Q2 2026 455.4k
9 ENGENE HOLDINGS INC COM COM 876,357 $1.5m0.82% 0.82% UnchangedShares held: Q3 2025 526.4k, Q4 2025 876.4k, Q1 2026 876.4k, Q2 2026 876.4k
10 ODYSSEY THERAPEUTICS INC COMMON STOCK ODTX ODTX 2,893 $54.1k0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.9k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
REPLIMUNE GROUP INC REPL REPL 248,672 $1.9m248.7k shares